Tazume K[Author] - Search Results

Year	Number of Results
2001	2
2002	2
2003	5
2004	1
2008	1
2014	2
2017	1
2022	1
2024	0

1

Low cerebrospinal fluid-to-plasma ratios of orally administered lenalidomide mediated by its low cell membrane permeability in patients with hematologic malignancies.

Ogiya D, Murayama N, Kamiya Y, Saito R, Shiraiwa S, Suzuki R, Machida S, Tazume K, Ando K, Yamazaki H. Ogiya D, et al. Among authors: tazume k. Ann Hematol. 2022 Sep;101(9):2013-2019. doi: 10.1007/s00277-022-04893-w. Epub 2022 Jun 22. Ann Hematol. 2022. PMID: 35732975

2

Clinicopathological Analysis of 320 Cases of Diffuse Large B-cell Lymphoma Using the Hans Classifier.

Ichiki A, Carreras J, Miyaoka M, Kikuti YY, Jibiki T, Tazume K, Watanabe S, Sasao T, Obayashi Y, Onizuka M, Ohmachi K, Yoshiba F, Shirasugi Y, Ogawa Y, Kawada H, Nakamura N, Ando K. Ichiki A, et al. Among authors: tazume k. J Clin Exp Hematop. 2017;57(2):54-63. doi: 10.3960/jslrt.17029. J Clin Exp Hematop. 2017. PMID: 29021515 Free PMC article.

3

Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's Lymphoma.

Kawada H, Sawanobori M, Tsuma-Kaneko M, Wasada I, Miyamoto M, Murayama H, Toyosaki M, Onizuka M, Tsuboi K, Tazume K, Shirasugi Y, Ohmachi K, Ogawa Y, Kobayashi H, Ando K. Kawada H, et al. Among authors: tazume k. Tokai J Exp Clin Med. 2014 Sep 20;39(3):111-5. Tokai J Exp Clin Med. 2014. PMID: 25248425 Free article. Clinical Trial.

4

Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.

Sato A, Nakamura N, Kojima M, Ohmachi K, Carreras J, Kikuti YY, Numata H, Ohgiya D, Tazume K, Amaki J, Moriuchi M, Miyamoto M, Aoyama Y, Kawai H, Ichiki A, Hara R, Kawada H, Ogawa Y, Ando K. Sato A, et al. Among authors: tazume k. Cancer Sci. 2014 Sep;105(9):1170-5. doi: 10.1111/cas.12467. Epub 2014 Sep 8. Cancer Sci. 2014. PMID: 24974976 Free PMC article.

5

Umbilical cord blood dendritic cells are a rich source of soluble HLA-DR: synergistic effect of exosomes and dendritic cells on autologous or allogeneic T-Cell proliferation.

Gansuvd B, Hagihara M, Higuchi A, Ueda Y, Tazume K, Tsuchiya T, Munkhtuvshin N, Kato S, Hotta T. Gansuvd B, et al. Among authors: tazume k. Hum Immunol. 2003 Apr;64(4):427-39. doi: 10.1016/s0198-8859(03)00016-8. Hum Immunol. 2003. PMID: 12651069

6

The effects of alphaGalCer-induced TCRValpha24 Vbeta11(+) natural killer T cells on NK cell cytotoxicity in umbilical cord blood.

Ueda Y, Hagihara M, Gansuvd B, Yu Y, Masui A, Okamoto A, Higuchi A, Tazume K, Kato S, Hotta T. Ueda Y, et al. Among authors: tazume k. Cancer Immunol Immunother. 2003 Oct;52(10):625-31. doi: 10.1007/s00262-003-0398-3. Epub 2003 Jun 12. Cancer Immunol Immunother. 2003. PMID: 12802518

7

Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.

Hagihara M, Gansuvd B, Ueda Y, Tsuchiya T, Masui A, Tazume K, Inoue H, Kato S, Hotta T. Hagihara M, et al. Among authors: tazume k. Cancer Immunol Immunother. 2002 Mar;51(1):1-8. doi: 10.1007/s00262-001-0246-2. Epub 2001 Dec 12. Cancer Immunol Immunother. 2002. PMID: 11845254

8

Secondary pulmonary alveolar proteinosis in a patient with chronic myeloid leukemia in the accelerated phase.

Ohmachi K, Ogiya D, Morita F, Kojima M, Tsuboi K, Tazume K, Komatsu M, Hayama N, Kumaki N, Ogawa Y, Ando K. Ohmachi K, et al. Among authors: tazume k. Tokai J Exp Clin Med. 2008 Dec 20;33(4):146-9. Tokai J Exp Clin Med. 2008. PMID: 21318986 Free article.

9

The in vitro generation of Ph1+ ALL-specific HLA-A24-restricted cytotoxic T lymphocytes using a synthetic 16 mer minor bcr-abl peptide.

Hagihara M, Tsuchiya T, Hyodo O, Ueda Y, Tazume K, Gansuvd B, Kato S, Hotta T. Hagihara M, et al. Among authors: tazume k. Leuk Res. 2003 Mar;27(3):253-7. doi: 10.1016/s0145-2126(02)00092-9. Leuk Res. 2003. PMID: 12537978

10

The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells.

Tsuchiya T, Hagihara M, Shimakura Y, Ueda Y, Gansuvd B, Munkhbat B, Inoue H, Tazume K, Kato S, Hotta T. Tsuchiya T, et al. Among authors: tazume k. Int J Hematol. 2002 Jan;75(1):55-62. doi: 10.1007/BF02981980. Int J Hematol. 2002. PMID: 11843292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year